Varex Imaging Corporation

NASDAQ:VREX

Medical - Devices

Healthcare
$18.15 +3.33%

+$0.34 today

Market cap
$770.71M
Beta
0.90
P/E (TTM)
-5.3
EPS (TTM)
-$1.97
52W Low $6.76High $14.57

Volume 0.73M

Average 0.36M

VREX Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

Varex Imaging CorporationNASDAQ: VREX

Accounts Receivables · Q2 FY2026 · quarter ended Apr 2026

Accounts receivables declines year over year

Q2 FY2026 accounts receivables of $1.1M (cash outflow) fell 86.1% year over year, ahead of the -169.8% change in trailing-twelve-month accounts receivables.

Context

  • Accounts receivables amounted to 0.0% of revenue in FY2025, down 0.8 pp from a year earlier.
  • Accounts receivables increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -86.1% holds above the trailing-twelve-month pace of -169.8%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterApr 2026
-$1.1M-112.4% QoQ
Last fiscal yearOct 2025
$100K-98.5% YoY
LTMApr 2026
-$3.7M-169.8% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-86.1%——
1 year-98.5%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2025
100K USD
Year-over-year change
-98.5%

Accounts Receivables vs competitors

How VREX compares with its peers on the latest reported figures

  • VREX's LTM Apr 2026 accounts receivables of $3.7M is the 3rd largest of the 5 companies compared; the peer median is $56.92K.
  • Its year-over-year change of -169.8% is the lowest of 5, against a peer median of +147.7%.
  • Accounts receivables amounts to 0.4% of revenue for VREX, versus a peer median of 1.4%.
VREX Competitors Peer median
Accounts Receivables for VREX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
GEHCGE HealthCare Technologies Inc.LTM Jun 2026$402M +166.2%-21.1%2.0%
OSISOSI Systems, Inc.LTM Jun 2026$98.67M +159.9%—5.5%
VREXVarex Imaging CorporationLTM Apr 2026$3.7M -169.8%—0.4%
NNOXNano-X Imaging Ltd.LTM Dec 2025$113.84K +135.5%+13.1%0.9%
BRKRBruker CorporationLTM Jun 2026$0 +100.0%—0.0%
Peer median (excluding VREX) $56.92K+147.7%-4.0%1.4%

Competitors are the stored peer set for VREX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Oct 2021
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Oct 2025
Net Income17.9M30.8M48.7M(47.2M)(69.9M)
Depreciation & Amortization37.3M33.6M33.2M31.1M27.2M
Deferred Income Tax(3M)600K(39.5M)37M(500K)
Stock-Based Compensation13.9M14M13.5M15.3M15M
Change in Working Capital8.2M(88M)23.3M2M(31.4M)
Accounts Receivables(32.9M)(18.1M)9.8M6.7M100K
Inventory42.8M(85M)20.2M6.6M(39.9M)
Accounts Payables(13.6M)19.7M(15M)(3.2M)6.2M
Other Working Capital11.9M(4.6M)8.3M(8.1M)2.2M
Other Non-Cash Items18.3M25.9M29.2M9.1M101.3M
Operating Cash Flow92.6M16.9M108.4M47.3M41.7M
Capital Expenditures(15.1M)(21.3M)(20.7M)(26.9M)(22.9M)
Acquisitions (Net)(1.4M)1.1M(1M)900K0
Purchases of Investments0(28.3M)(55.9M)(61M)(31.4M)
Sales of Investments02M28.3M60.6M65.4M
Other Investing Activities300K(1.9M)4.4M(1.1M)(800K)
Investing Cash Flow(16.2M)(48.4M)(44.9M)(27.5M)10.3M
Debt Repayment(31.6M)(29.4M)(2.4M)(1.6M)(75M)
Common Stock Issued00003.3M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(700K)5.6M2.2M(1.7M)(4.2M)
Financing Cash Flow(32.3M)(23.8M)(200K)(3.3M)(75.9M)
Effect of Forex Changes(100K)(200K)100K(100K)600K
Net Change in Cash44M(55.5M)63.4M16.4M(23.3M)
Free Cash Flow77.5M(4.4M)87.7M20.4M18.8M

Varex Imaging Corporation

NASDAQ:VREX

Intrinsic Alpha fair value

Locked

Current Price

$18.15

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.